Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Abbott NORTHAMPTON ... has achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment ...

As of February 20, 2025, its stock price has risen 17.8% year-to-date, outperforming the broader medical sector and key competitors like Abbott ... emerging field of pulsed field ablation ...

As of February 20, 2025, its stock price has risen 17.8% year-to-date, outperforming the broader medical sector and key competitors like Abbott ... emerging field of pulsed field ablation ...

A new procedure, pulsed field ablation, or PFA, uses short bursts of electricity ... degenerate and stretch over time creating a redundancy of tissue, Chanin said. The Abbott Tricuspid TriClip pulls ...

According to Research by SNS Insider, The Pulsed Field Ablation Market Growth is Driven by Technological Advancements and Rising Prevalence of Atrial FibrillationPune, March 20, 2025 (GLOBE NEWSWIRE) ...